Literature DB >> 6129580

Nephrotoxicity of radiocontrast media in ischemic renal failure in rabbits.

S G Schultz, K J Lavelle, R Swain.   

Abstract

Ischemic renal failure was produced in rabbits by occluding the renal arteries for 90 min. Group 1 (n = 8) received radiocontrast media at the time of occlusion, group 2 (n = 8) 24 h after occlusion, and group 3 (n = 8) 3 days after occlusion. Group 4 (n = 12) was subjected to ischemic injury alone, group 5 (n = 4) served as sham-operated controls and group 6 (n = 4) did not undergo surgery but received radiocontrast media. Serum creatinine concentration in group 1 increased to a greater degree (p less than 0.001) than all other groups and did not return to normal during the 8-day observation period. Creatinine concentration in groups 2, 3, 4, and 6 were comparable and significantly increased compared to sham-operated group (p less than 0.05). Urinary excretion of alanine aminopeptidase and N-acetyl-beta-glucosaminidase in group 1 was significantly greater than all other groups (p less than 0.05). Microscopic analysis indicated tubular necrosis was more prominent in group 1. Radiocontrast media is nephrotoxic and in the setting of ischemic injury may prevent recovery of renal function. Toxicity was dependent on the time of administration since functional impairment was not increased if dye was given 1 or 3 days after ischemic injury.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6129580     DOI: 10.1159/000182829

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  Ringer's ethyl pyruvate solution attenuates hypoperfusion and renal injury after multivisceral ischemia-reperfusion in rabbits.

Authors:  Takashige Yamada; Daisuke Nishimura; Kei Inoue; Jungo Kato; Hiroshi Morisaki; Yoshifumi Kotake
Journal:  J Anesth       Date:  2020-01-09       Impact factor: 2.078

2.  Acute renal failure with selective medullary injury in the rat.

Authors:  S N Heyman; M Brezis; C A Reubinoff; Z Greenfeld; C Lechene; F H Epstein; S Rosen
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.